Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
Kevin R. Kelly(Keck Hospital of USC), Steffan T. Nawrocki(University of Arizona), Valeria Visconte(Cleveland Clinic), Jennifer S. Carew(University of Arizona), Kaijin Wu(University of Southern California), Claudia M. Espitia(The University of Texas System), Christine M. Calton(University of Arizona), Weiguo Zhao(The University of Texas at San Antonio Health Science Center), Faiz Anwer(Cleveland Clinic)
Cited by 72
Related Papers
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
|Cancer Letters|2008|426
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
|Clinical Cancer Research|2015|355